Doseology Sciences

03/04/2026

Energy has a new format. 🚀

Today Doseology launches Feed That Brain - Slim Nootropic Energy Pouches.

These deliver precise stimulation without the bulk of traditional energy drinks or densly packed “health” bars.

Zero mixing.
Zero sugar.
Zero crash.

Just controlled caffeine and intelligent dosing in a slim pouch.

Energy intelligence, engineered for immediate clarity without the spike. 🧠

And in case you didn’t notice, it’s in juicy watermelon flavor. 🍉

Exclusively available in the United States at feedthatbrain.com and Amazon. 🇺🇸

Questions? Come visit feedthatbrain.com and sign up to be a part of the new FTB Focus Lab and help us engineer what’s next.

02/20/2026

Welcoming Larry Latowsky as Executive Chairman of Doseology’s Board.

Larry brings deep experience in corporate governance and regulated healthcare, including leading Katz Group Canada’s 1,500-location pharmacy network and its C$3B acquisition by McKesson. He also served as Chairman of Well.ca, one of Canada’s leading health and wellness e-commerce platforms.

Strengthening our retail, digital, and operational foundation as we scale.

Read our latest news update: https://doseology.com/2026/02/20/doseology-appoints-larry-latowsky-as-executive-chairman-of-the-board-of-directors/

02/20/2026

Doseology News: Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors - Read the News Release: https://doseology.com/2026/02/20/doseology-appoints-larry-latowsky-as-executive-chairman-of-the-board-of-directors/

CSE: MOOD

01/21/2026

Pilot production is underway for caffeine-based energy pouches under our Feed That Brain® brand.

No ni****ne. No excess. Just measured, predictable energy in a controlled pouch format.

This early pilot will help inform future decisions across formulation, delivery, and scalability within our broader oral stimulant platform.

🔗 Read more via link in bio
(CSE: MOOD | PINK: DOSEF | FSE: VU70)

01/16/2026

Doseology has filed its Annual Information Form (AIF) for the fiscal year ended June 30, 2025 on SEDAR+, reinforcing our commitment to transparency, governance discipline, and clear communication as a public company. The AIF brings together key information on our business, strategy, and governance in one accessible place for investors and stakeholders.

Transparency.
Accountability.
Long-term focus

🔗 Press release: https://doseology.com/2026/01/16/doseology-files-annual-information-form-aif-strengthening-public-disclosure-record-aif-filing-enhances-transparency-and-provides-consolidated-disclosure-for-investors/

01/12/2026

Strong products start with strong foundations.

Doseology has engaged McKinney Regulatory Advisors to guide science-based development and regulatory strategy for our oral pouch platform.

🔗 Press release: https://doseology.com/category/news/

11/13/2025

Doseology has reached a pivotal milestone, completing extensive North American diligence and securing a strategic U.S. manufacturing agreement through its subsidiary, Doseology USA Inc. This partnership gives the Company the commercial infrastructure, regulatory strength, and scalable production capacity needed to move from R&D into full market readiness. For investors, it signals disciplined ex*****on, lowered operational risk, and a clear path toward commercialization in the fast-growing oral stimulant pouch category.

Read the News Release: https://doseology.com/2025/11/13/doseology-completes-extensive-north-american-diligence-securing-strategic-manufacturing-agreement/

(CSE: MOOD | PINK: DOSEF | FSE: VU70)

08/19/2025

Doseology x Feed That Brain

We’ve acquired , a brand built on cognitive performance and wellness.

This strengthens our launch into clean energy pouches, designed for focus, energy, and performance without the crash.

We’re also welcoming Joseph Mimran (the creator of Joe Fresh & Club Monaco) as our new Strategic Advisor. His legendary brand-building experience will help us push Doseology to the next level.

Fueling the Future of Performance!

07/17/2025

Doseology is proud to announce the appointment of Patrick W. Sills as our Strategic Go‑to‑Market Advisor!

With over 15 years of leadership across Philip Morris, Fontem Ventures, and his own consultancy, Patrick brings deep expertise in commercial strategy, regulatory compliance, and international market expansion.

As we scale our precision-formulated oral stimulant line, Patrick will spearhead:
– Product positioning & distribution strategy
– Regulatory navigation across North America, LATAM, and EU
– Accelerated market launches

With the oral ni****ne pouch segment growing ~13% YoY (NielsenIQ via Goldman Sachs), we’re entering a major growth phase.

Patrick’s track record in highly regulated industries makes him the perfect partner as we execute with acuity, speed, and strategic discipline.

Welcome aboard, Patrick! 👏

Read the full release here: https://doseology.com/blogs/investor-news/doseology-appoints-patrick-w-sills-as-strategic-go-to-market-advisor